The impact of prior platinum therapy on survival in patients with metastatic urothelial cancer receiving vinflunine

BACKGROUND: A phase III trial demonstrated an overall survival advantage with the addition of vinflunine to best supportive care (BSC) in platinum-refractory advanced urothelial cancer. We subsequently examined the impact of an additional 2 years of survival follow-up and evaluated the influence of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Harshman, L C, Fougeray, R, Choueiri, T K, Schutz, F A, Salhi, Y, Rosenberg, J E, Bellmunt, J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2013
Konular:
Clinical Study
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3833211/
https://ncbi.nlm.nih.gov/pubmed/24129239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.617
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller